Browsing Category
Medicine
Pfizer: Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with…
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2022. The purpose of the call is to provide an update on!-->…
Pfizer: Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for…
Pfizer Inc. (NYSE: PFE) announced today an agreement to supply up to six million treatment courses of its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets) to Global Fund as part of its COVID-19 Response!-->…
Pfizer: Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for…
New York, NY, and Brisbane, California, September 22, 2022 - Pfizer and Sangamo Therapeutics announced that the Phase 3 AFFINE study evaluating giroctocogene fitelparvovec, an investigational gene therapy for patients with moderately!-->…
Aster Hospitals Bangalore launches ‘Aster International Institute of Oncology’
Bangalore : Aster Hospitals Bangalore, a unit of Aster DM Healthcare has launched an institute of oncology under the banner - Aster International Institute of Oncology (AIIO) today. This newly launched institute will be the centre of…
Pfizer: Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended converting the conditional Marketing!-->…
Pfizer: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 Vaccine (COMIRNATY® Original/Omicron BA.4/BA.5 15/15 µg) has been recommended for conditional!-->…
HKUMed research team estimates over 30% elevated risk of breast cancer among antipsychotic users
A research team from the Centre for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) conducted the world’s first systematic review and…
Malaria booster vaccine shows durable high efficacy in African children, meeting WHO-specified 75%…
Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ – which previously…
Pfizer: FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine…
Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the!-->…
Dettol launches India’s first Hygiene Olympiad under its Dettol Banega Swasth India initiative
Reckitt, world’s leading consumer health and hygiene company, under its flagship campaign Dettol Banega Swasth India today launched India’s first and biggest Hygiene Olympiad - Dettol Hygiene Olympiad. Built on the fundamentals of good…